ANI Pharmaceuticals
ANIP
ANIP
138 hedge funds and large institutions have $411M invested in ANI Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 34 increasing their positions, 50 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
8% less call options, than puts
Call options by funds: $718K | Put options by funds: $778K
32% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 50
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
138
Holding in Top 10
1
Calls
$718K
Puts
$778K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$4.13M | |
| 3 | +$3.01M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$2.07M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.39M |
Top Sellers
| 1 | -$6.16M | |
| 2 | -$3.09M | |
| 3 | -$2.77M | |
| 4 |
BlackRock
New York
|
-$1.66M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.07M |